Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × X-Rays × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 18 Lung Neoplasms 13 Multiple Myeloma 11 Leukemia, Myeloid, Acute 8 Glioma 8 Carcinoma, Non-Small-Cell Lung 8 Wilms Tumor 7 Sarcoma 7 Osteosarcoma 7 Neuroblastoma 7 Neoplasm Metastasis 7 Lymphoma, Non-Hodgkin 7 Breast Neoplasms 7 Rhabdoid Tumor 6 Ovarian Neoplasms 6 Myelodysplastic Syndromes 6 Hepatoblastoma 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 6 Neuroectodermal Tumors, Primitive, Peripheral 5 Medulloblastoma 5 Leukemia, Myelomonocytic, Chronic 5 Histiocytosis, Langerhans-Cell 5 Ependymoma 5 Triple Negative Breast Neoplasms 4 Sarcoma, Ewing 4 Rhabdomyosarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mouth Neoplasms 4

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡